Data as of Q4 2025 (Dec 31, 2025)

Palo Alto Investors LP

โ€ขCIK: 1306923โ€ขFiling: Q4 2025

**Palo Alto Investors LP** manages $718M across a concentrated portfolio of 49 positions. The fund exhibits significant conviction in select names, with top holdings including IM8N at $85.2M and AM6 at $74.1M. Further substantial allocations are evident in PTCT ($68.7M) and ACAD ($66.3M). This structure suggests a deep-value, high-conviction approach targeting established growth leaders.

Total AUM
$718.4M
QoQ Performance
+32.9%
Positions
49
Top 10 Concentration
67.8%
Latest Filing
Q4 2025

Top Holdings Allocation

IM8N
AM6
PTCT
ACAD
BMRN
IM8N11.9%
AM610.3%
PTCT9.6%
ACAD9.2%
BMRN6.2%
ANAB4.7%
BIIB4.5%
DYN4.0%

๐Ÿ“ˆ Biggest Buys

CMPX
COMPASS THERAPEUTICS INC
NEW
1.9% of portfolio
ANNX
ANNEXON INC
NEW
1.7% of portfolio
IRON
DISC MEDICINE INC
+41.5%
3.5% of portfolio
MIRM
MIRUM PHARMACEUTICALS INC
+141.8%
1.7% of portfolio
CAPR
CAPRICOR THERAPEUTICS INC
NEW
0.9% of portfolio

๐Ÿ“‰ Biggest Sells

NUVB
NUVATION BIO INC
-47.3%
0.7% of portfolio
GOSS
GOSSAMER BIO INC
-18.2%
1.9% of portfolio
AM6
AMICUS THERAPEUTICS INC
-3.0%
10.3% of portfolio
AGIO
AGIOS PHARMACEUTICALS INC
-20.0%
0.8% of portfolio
IOVA
IOVANCE BIOTHERAPEUTICS INC
-6.6%
2.7% of portfolio

Sector Breakdown

Other99.9%
Healthcare0.1%

๐Ÿšช Exited Positionssold since Q3 2025

ALNY
ALNYLAM PHARMACEUTICALS INC
SOLD
$14.7M
RNAGBP
AVIDITY BIOSCIENCES INC
SOLD
$4.8M
GBIOGBX
GENERATION BIO CO
SOLD
$92.1K

Changes from Q3 2025

NEW8 new positions
โ†‘12 increased
โ†“13 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023